Taiwan

With a strong growth market for drug development, dense population, and a universal healthcare system, Taiwan is an ideal location for clinical trials.

George Clinical In Taiwan

Taiwan is one of George Clinical’s fastest-growing Asian hubs.  With a strong growth market for drug development, a dense population, and a universal healthcare system, Taiwan is an ideal location for clinical trials. George Clinical’s on-the-ground clinical team leader oversees a number of our CRAs and CTAs in delivering customer projects across Taiwan. The Center for Drug Evaluation (CDE) was established by the Ministry of Health and Welfare (MOHW) to assist the Taiwan Food and Drug Administration (TFDA) in the technical review of new drugs, medical devices and clinical trials to fulfill regulatory requirements.

The MOHW regularly accredits sites for clinical trial conduct, where the certificate is valid for four years. There are 128 qualified sites for conducting clinical trials in Taiwan. Known centers for excellence include the National Taiwan University Hospital, which currently runs more than 600 clinical trials, including 43 Phase I clinical trials; and Chang Gung Memorial Hospital, which currently runs more than 500 clinical trials. There is strong government support for clinical trials.

What are the benefits of conducting clinical trials in Taiwan?

  • Taiwan is a strong growth market for drug development
  • Approximately 80% of trials in Taiwan are multinational trials
  • Almost 100% of Taiwanese nations are covered by the National Health Insurance (NHI) program, which provides universal quality healthcare to its population at an affordable cost
  • Clinical Trial Notification and c-IRB Mechanisms provide a fast study start-up timeline

Why is George Clinical the CRO of choice for our sponsors in Taiwan?

  • Experienced team managing Phase I to IV clinical trials.
  • Established network

Contact

George Clinical Address:
Level 37, TAIPEI 101 Tower, No.7, Section 5, Xinyi Road,
Taipei 110 Taiwan

East Asia Contact Number: +60 (3) 7610 0725

Details

Population 23.5 million
Official Language Mandarin Chinese (official), Taiwanese (Min), Hakka, Aboriginal dialects
Hospital Records Language English and Traditional Chinese
Electronic Hospital Records All Taiwanese hospitals utilize a standard form of electronic medical records
Site Network Only accredited teaching hospitals are able to carry out human clinical trials. There are approximately 128 qualified clinical trial sites in Taiwan
In-country services Clinical Operations
Regulatory Services
GDP – per capita (US $) $24,318

Add George Clinical to your network